Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized Trial

The efficacy and safety of a reduced dose of prasugrel versus a standard dose of ticagrelor in elderly patients or those with a low body weight presenting with an acute coronary syndrome (ACS) are unknown. To investigate the effect of an age- and weight-adapted dose of prasugrel versus a standard do...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Annals of internal medicine Ročník 173; číslo 6; s. 436
Hlavní autoři:	Menichelli, Maurizio, Neumann, Franz-Josef, Ndrepepa, Gjin, Mayer, Katharina, Wöhrle, Jochen, Bernlochner, Isabell, Richardt, Gert, Witzenbichler, Bernhard, Sibbing, Dirk, Gewalt, Senta, Angiolillo, Dominick J, Lahu, Shqipdona, Hamm, Christian W, Hapfelmeier, Alexander, Trenk, Dietmar, Laugwitz, Karl-Ludwig, Schunkert, Heribert, Schüpke, Stefanie, Kastrati, Adnan
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 15.09.2020
Témata:	Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - mortality Age Factors Aged Body Weight Drug Dosage Calculations Female Hemorrhage - chemically induced Humans Male Middle Aged Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - therapeutic use Prasugrel Hydrochloride - administration & dosage Prasugrel Hydrochloride - adverse effects Prasugrel Hydrochloride - therapeutic use Ticagrelor - adverse effects Ticagrelor - therapeutic use Treatment Outcome
ISSN:	1539-3704, 1539-3704
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!